Cryoport, Inc.

CYRX

Cryoport, Inc.

CYRX

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-11Shares Purchased (TTM):0Shares Sold (TTM):284,050

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:43,821,778Shares Outstanding:49,897,817Institutional Ownership Pct.:87.82%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Convertible Preferred Stock	-	0	0	-0	0	0	0	0	0	0	0	0
Class B Convertible Preferred Stock	-	0	0	-0	0	0	0	0	0	0	0	0
Class C Convertible Preferred Stock	-	0	0	0	0	0	0	0	0	0	0	-0
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	269	273	250	256	243	36	34	31	34	39	46	59
Short Term Investments	127	131	161	166	183	208	216	228	381	399	410	406
Accounts Receivable Net Current	36	39	33	35	33	28	25	43	40	41	42	43
Inventory Net	22	22	23	23	23	23	21	24	24	25	26	29
Prepaid Expense And Other Assets Current	6	6	8	5	7	7	8	11	11	11	10	12
Assets Of Disposal Group Including Discontinued Op…	-	-	-	-	-	108	36	-	-	-	-	-
Assets Current	460	471	476	485	489	411	342	350	502	526	535	549
Property Plant And Equipment Net	95	90	85	83	82	80	80	88	87	86	85	75
Operating Lease Right Of Use Asset	40	39	40	40	38	39	40	30	30	31	33	33
Finite Lived Intangible Assets Net	136	139	138	141	144	145	148	176	178	190	194	193
Goodwill	22	22	22	22	19	21	21	54	52	108	108	149
Deposits Assets	2	2	2	2	2	2	2	1	2	2	2	2
Deferred Income Tax Assets Net	1	1	1	0	0	1	1	2	2	1	1	1
Disposal Group Including Discontinued Operation As…	-	-	-	-	-	-	71	-	-	-	-	-
Assets	756	764	765	774	774	700	703	702	852	943	958	1,001
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	16	16	15	14	15	13	16	25	25	27	27	28
Employee Related Liabilities Current	12	17	13	11	9	13	11	11	11	14	11	10
Contract With Customer Liability Current	2	2	1	1	2	2	1	1	1	2	1	2
Operating Lease Liability Current	4	4	4	4	4	4	3	6	5	5	5	5
Finance Lease Liability Current	-	0	0	0	0	0	0	0	0	0	0	0
Convertible Debt Current	186	185	185	-	-	14	14	14	14	-	-	-
Notes Payable Current	0	0	0	-	-	0	0	0	0	0	0	0
Business Combination Contingent Consideration Liab…	-	-	-	-	-	-	3	3	3	-	0	-
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	28	15	-	-	-	-	-
Liabilities Current	221	225	219	31	30	74	65	61	60	49	46	45
Convertible Debt Noncurrent	-	-	-	185	185	184	184	184	356	379	379	378
Long Term Notes Payable	1	1	1	1	1	1	1	1	1	1	1	0
Operating Lease Liability Noncurrent	40	39	39	39	37	38	39	26	27	28	29	30
Finance Lease Liability Noncurrent	-	1	1	1	1	1	1	1	1	1	1	1
Deferred Income Tax Liabilities Net	2	2	1	1	1	1	1	4	3	2	3	5
Other Liabilities Noncurrent	1	1	0	3	3	1	0	1	0	0	1	0
Business Combination Contingent Consideration Liab…	-	1	1	1	1	1	4	5	5	10	9	4
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	-	8	-	-	-	-	-
Liabilities	266	269	262	261	259	301	302	283	452	471	469	463
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	1,155	1,153	1,153	1,152	1,151	1,147	1,146	1,141	1,138	1,135	1,131	1,127
Retained Earnings Accumulated Deficit	-708	-699	-689	-675	-668	-769	-757	-738	-739	-661	-642	-580
Accumulated Other Comprehensive Income Loss Net Of…	-2	-3	-3	-4	-5	-16	-21	-16	-29	-30	-26	-34
Stockholders Equity	491	495	503	513	519	399	402	419	400	472	489	538
Liabilities And Stockholders Equity	756	764	765	774	774	700	703	702	852	943	958	1,001
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	3	3	3	3	3	3	3	3	3	3	3	3
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	100	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	51	50	50	50	50	50	50	49	49	49	49	49
Shares Outstanding	51	50	50	50	50	50	50	49	49	49	49	49

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	28.71%	31.26%	26.09%	-	-	-	-	-	-	-	-	-
2025	-13.90%	6.16%	12.46%	21.91%	14.02%	8.83%	15.49%	15.97%	24.73%	-6.46%	26.67%	67.46%
2024	-22.12%	-47.65%	-33.26%	14.22%	-1.96%	-15.56%	-11.72%	-2.74%	-0.12%	-2.25%	-7.54%	-3.05%
2023	-	-	-	3.96%	0.44%	-32.82%	31.15%	37.08%	33.98%	26.81%	11.07%	-28.41%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.08	2.09	2.17	15.77	16.24	5.56	5.29	5.70	8.38	10.73	11.73	12.23
Quick Ratio	1.96	1.97	2.03	14.84	15.24	5.14	4.83	5.15	7.80	10.00	10.94	11.32
Working Capital	239.17M	245.67M	257.16M	454.09M	459.34M	337.25M	277.01M	288.90M	442.10M	476.72M	489.50M	504.24M
Leverage & Debt
Debt to Equity	0.54	0.54	0.52	0.51	0.50	0.75	0.75	0.68	1.13	1.00	0.96	0.86
Interest Coverage TTM	-18.78	-17.75	-15.59	-17.14	-16.14	-33.90	-30.12	-37.51	-34.78	-23.00	-20.93	-9.96
Debt Ratio	0.35	0.35	0.34	0.34	0.33	0.43	0.43	0.40	0.53	0.50	0.49	0.46
Efficiency & Turnover
Asset Turnover TTM	0.24	0.25	0.24	0.23	0.20	0.20	0.19	0.20	0.20	0.21	0.23	0.23
Days Sales Outstanding TTM	68.38	67.21	60.77	83.07	80.75	79.16	78.44	91.04	79.78	76.28	67.23	67.21
Receivables Turnover TTM	5.34	5.43	6.01	4.39	4.52	4.61	4.65	4.01	4.58	4.78	5.43	5.43
Per Share Metrics
Diluted EPS TTM	-0.90	1.44	1.40	1.22	1.37	-2.36	-2.49	-3.37	-3.66	-2.43	-2.21	-0.99
Free Cash Flow Per Share TTM	-0.40	-0.48	-0.50	-0.62	-0.67	-0.68	-0.68	-0.65	-0.79	-0.82	-0.81	-0.71
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	47.08%	47.19%	47.14%	46.95%	46.28%	45.62%	44.43%	42.55%	42.15%	42.04%	42.59%	43.30%
Operating Profit Margin TTM	-21.25%	-21.44%	-20.89%	-22.95%	-25.85%	-69.37%	-77.61%	-103.60%	-95.75%	-59.03%	-49.37%	-23.83%
Net Profit Margin TTM	-24.34%	39.22%	39.90%	35.58%	41.51%	-73.41%	-78.30%	-96.46%	-94.81%	-57.24%	-46.12%	-20.58%
Growth Metrics
Net Revenue Growth (1Y)	12.14%	13.97%	12.38%	-0.23%	-12.68%	-22.73%	-32.79%	-26.98%	-20.88%	-16.17%	-1.70%	1.28%
Net Income Growth (1Y)	-165.76%	-160.88%	-157.27%	-136.80%	-138.23%	-0.90%	14.10%	242.29%	343.80%	277.45%	188.18%	-82.86%
EPS Growth (1Y)	-165.52%	-160.94%	-156.44%	-136.29%	-137.53%	-2.74%	12.68%	238.73%	338.08%	272.39%	189.66%	-83.00%
Valuation Metrics
P/E TTM	-17.45	5.76	6.84	7.76	5.43	-2.58	-3.13	-2.41	-1.89	-7.30	-7.02	-13.79
P/B TTM	1.61	0.83	0.96	0.93	0.72	0.76	0.96	0.96	0.85	1.84	1.54	1.25
P/S TTM	4.25	2.26	2.73	2.76	2.25	1.89	2.45	2.32	1.79	4.18	3.24	2.84
Market Cap	791.95M	413.15M	480.69M	475.19M	374.92M	303.68M	383.94M	400.78M	340.98M	867.65M	754.94M	670.48M
Enterprise Value	709.52M	327.92M	417.70M	406.73M	318.70M	457.22M	550.39M	557.18M	679.57M	1.21B	1.09B	990.16M
Calculated Values
Free Cash Flow TTM	-20.03M	-23.76M	-25.02M	-31.17M	-33.70M	-33.82M	-33.58M	-31.97M	-39.11M	-40.02M	-39.54M	-34.65M
Net Debt	-82.44M	-85.24M	-62.99M	-68.45M	-56.22M	153.55M	166.45M	156.40M	338.60M	342.49M	334.93M	319.69M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-11Sale

Owner: Zecchini, Edward J

Title: Chief Digital and Tech Officer

Shares: 33,600

Price/Share: $14.47

Value: $486,192.00

Shares Owned: 109,719

Relationship: Officer

Ownership: Direct

2026-06-08Sale

Owner: Mandalam, Ramkumar

Title: -

Shares: 23,214

Price/Share: $15.44

Value: $358,424.16

Shares Owned: 67,894

Relationship: Director

Ownership: Direct

2026-06-04Sale

Owner: Stefanovich, Robert

Title: Chief Financial Officer

Shares: 169,427

Price/Share: $16.27

Value: $2,756,577.29

Shares Owned: 109,850

Relationship: Officer

Ownership: Direct

2026-03-23Sale

Owner: Sawicki, Mark W

Title: Chief Scientific Officer

Shares: 1,341

Price/Share: $8.18

Value: $10,969.38

Shares Owned: 102,356

Relationship: Officer

Ownership: Direct

2026-03-23Sale

Owner: Stefanovich, Robert

Title: Chief Financial Officer

Shares: 1,094

Price/Share: $8.18

Value: $8,948.92

Shares Owned: 279,277

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-11	Zecchini, Edward J	Officer	Chief Digital and Tech Officer	Direct	Sale	33,600	14.47	$486,192.00	109,719	4
2026-06-08	Mandalam, Ramkumar	Director	-	Direct	Sale	23,214	15.44	$358,424.16	67,894	4
2026-06-04	Stefanovich, Robert	Officer	Chief Financial Officer	Direct	Sale	169,427	16.27	$2,756,577.29	109,850	4
2026-03-23	Sawicki, Mark W	Officer	Chief Scientific Officer	Direct	Sale	1,341	8.18	$10,969.38	102,356	4
2026-03-23	Stefanovich, Robert	Officer	Chief Financial Officer	Direct	Sale	1,094	8.18	$8,948.92	279,277	4
2026-03-23	Shelton, Jerrell	Director,Officer	President, CEO	Direct	Sale	2,894	8.18	$23,672.92	1,051,607	4
2026-03-16	Sawicki, Mark W	Officer	Chief Scientific Officer	Direct	Sale	3,235	8.00	$25,880.00	103,697	4
2026-03-16	Stefanovich, Robert	Officer	Chief Financial Officer	Direct	Sale	2,743	8.00	$21,944.00	280,371	4
2026-03-16	Shelton, Jerrell	Director,Officer	President, CEO	Direct	Sale	7,918	8.00	$63,344.00	1,054,501	4
2026-03-16	Zecchini, Edward J	Officer	See Remarks	Direct	Sale	2,014	8.00	$16,112.00	109,719	4
2025-12-10	Mandalam, Ramkumar	Director	-	Direct	Sale	11,570	9.99	$115,584.30	80,758	4
2025-09-11	Hariri, Robert J	Director	-	Direct	Sale	25,000	9.71	$242,750.00	51,275	4
2025-08-22	Hariri, Robert J	Director	-	Direct	Sale	5,000	8.60	$43,000.00	26,275	4
2025-08-19	Stefanovich, Robert	Officer	Chief Financial Officer	Direct	Sale	9,300	8.67	$80,631.00	207,213	4
2025-07-22	Mandalam, Ramkumar	Director	-	Direct	Sale	40,728	7.24	$294,870.72	92,328	4
2025-06-24	Shelton, Jerrell	Director,Officer	President, CEO	Direct	Sale	16,344	7.06	$115,388.64	912,419	4
2025-06-24	Mandalam, Ramkumar	Director	-	Direct	Sale	13,321	7.02	$93,513.42	73,056	4
2025-06-20	Shelton, Jerrell	Director,Officer	President, CEO	Direct	Sale	69,135	6.47	$447,303.45	912,419	4
2025-06-13	Mandalam, Ramkumar	Director	-	Direct	Sale	624	6.80	$4,243.20	66,377	4
2025-06-10	Zecchini, Edward J	Officer	Chief Digital and Tech Officer	Direct	Sale	51,500	6.85	$352,775.00	90,411	4
2025-06-09	Mandalam, Ramkumar	Director	-	Direct	Sale	5,622	7.06	$39,691.32	77,089	4
2025-05-28	Hariri, Robert J	Director	-	Direct	Sale	12,500	6.10	$76,250.00	8,061	4
2025-03-24	Shelton, Jerrell	Director,Officer	President, CEO	Direct	Sale	2,980	6.94	$20,681.20	762,419	4
2025-03-24	Stefanovich, Robert	Officer	Chief Financial Officer	Direct	Sale	1,070	6.94	$7,425.80	190,349	4
2025-03-24	Sawicki, Mark W	Officer	Chief Scientific Officer	Direct	Sale	1,349	6.94	$9,362.06	84,087	4
2025-03-17	Stefanovich, Robert	Officer	Chief Financial Officer	Direct	Sale	1,659	6.29	$10,435.11	191,419	4
2025-03-17	Sawicki, Mark W	Officer	Chief Scientific Officer	Direct	Sale	2,092	6.29	$13,158.68	85,436	4
2025-03-17	Shelton, Jerrell	Director,Officer	President, CEO	Direct	Sale	4,620	6.29	$29,059.80	765,399	4
2025-03-17	Zecchini, Edward J	Officer	Chief Digital and Tech Officer	Direct	Sale	1,140	6.29	$7,170.60	66,911	4
2025-03-10	Sawicki, Mark W	Officer	Chief Scientific Officer	Direct	Sale	1,583	4.88	$7,725.04	78,528	4
2025-03-10	Shelton, Jerrell	Director,Officer	President, CEO	Direct	Sale	4,173	4.88	$20,364.24	740,019	4
2025-03-10	Stefanovich, Robert	Officer	Chief Financial Officer	Direct	Sale	1,256	4.88	$6,129.28	183,078	4
2024-12-02	Mandalam, Ramkumar	Director	-	Direct	Sale	7,369	7.46	$54,972.74	59,497	4
2024-11-22	Shelton, Jerrell	Director,Officer	President, CEO	Direct	Sale	22,817	6.47	$147,625.99	735,942	4
2024-11-21	Hariri, Robert J	Director	-	Direct	Sale	2,500	6.48	$16,200.00	20,561	4
2024-11-20	Shelton, Jerrell	Director,Officer	President, CEO	Direct	Sale	50,000	6.65	$332,500.00	722,747	4
2024-08-19	Hariri, Robert J	Director	-	Direct	Sale	1,000	9.47	$9,470.00	23,061	4
2024-08-16	Hariri, Robert J	Director	-	Direct	Sale	1,000	9.00	$9,000.00	23,561	4
2024-08-02	Mandalam, Ramkumar	Director	-	Direct	Sale	4,167	8.04	$33,502.68	56,032	4
2024-05-15	Berman, Richard J	Director	-	Direct	Sale	8,105	13.41	$108,688.05	100,000	4
2024-05-14	Zecchini, Edward J	Officer	Chief Digital and Tech Officer	Direct	Sale	3,443	13.37	$46,032.91	60,051	4
2024-03-25	Shelton, Jerrell	Director,Officer	Chief Executive Officer	Direct	Sale	2,631	17.54	$46,147.74	692,182	4
2024-03-25	Sawicki, Mark W	Officer	Chief Scientific Officer	Direct	Sale	1,367	17.54	$23,977.18	77,444	4
2024-03-25	Stefanovich, Robert	Officer	Chief Financial Officer	Direct	Sale	1,079	17.54	$18,925.66	128,333	4
2024-03-15	Sawicki, Mark W	Officer	Chief Scientific Officer	Direct	Sale	1,312	15.43	$20,244.16	73,061	4
2024-03-15	Mandalam, Ramkumar	Director	-	Direct	Sale	3,217	14.68	$47,225.56	43,187	4
2024-03-15	Shelton, Jerrell	Director,Officer	President, CEO	Direct	Sale	57,039	17.92	$1,022,138.88	634,352	4
2024-03-15	Stefanovich, Robert	Officer	Chief Financial Officer	Direct	Sale	1,035	15.43	$15,970.05	123,662	4
2023-12-14	Hariri, Robert J	Director	-	Direct	Sale	800	16.89	$13,512.00	12,716	4
2023-12-11	Hariri, Robert J	Director	-	Direct	Sale	1,000	15.50	$15,500.00	13,516	4
2023-09-06	Hariri, Robert J	Director	-	Direct	Sale	1,500	13.60	$20,400.00	14,516	4
2023-09-01	Shelton, Jerrell	Director,Officer	See Remarks	Direct	Sale	26,875	14.27	$383,506.25	632,424	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

87.82%

Inst. Shares: 43,821,778

Shares Outstanding: 49,897,817

2025-12-31

84.59%

Inst. Shares: 42,356,339

Shares Outstanding: 50,071,665

2025-09-30

89.84%

Inst. Shares: 45,032,648

Shares Outstanding: 50,125,268

2025-06-30

86.14%

Inst. Shares: 43,293,462

Shares Outstanding: 50,257,112

2025-03-31

86.11%

Inst. Shares: 43,008,621

Shares Outstanding: 49,947,012

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	43,821,778	49,897,817	87.82%
2025-12-31	42,356,339	50,071,665	84.59%
2025-09-30	45,032,648	50,125,268	89.84%
2025-06-30	43,293,462	50,257,112	86.14%
2025-03-31	43,008,621	49,947,012	86.11%
2024-12-31	44,951,187	49,349,624	91.09%
2024-09-30	43,993,328	49,417,757	89.02%
2024-06-30	45,976,620	49,345,644	93.17%
2024-03-31	48,198,823	49,019,964	98.32%
2023-12-31	47,081,844	48,737,377	96.60%
2023-09-30	42,696,504	48,904,102	87.31%
2023-06-30	41,806,146	48,709,384	85.83%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Cryoport, Inc. (CYRX) — SEC Financial Statements & Analysis

Cryoport, Inc. (CYRX) is a pharmaceutical preparations company, incorporated in NV. Cryoport, Inc. trades on Nasdaq as: CYRX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Cryoport, Inc. reported a 12.14% year-over-year revenue growth, a Gross Profit Margin of 47.08% (TTM), a Debt-to-Equity ratio of 0.54x, a Price-to-Sales (P/S) ratio of 4.25x (TTM), a Price-to-Book (P/B) ratio of 1.61x (TTM), at a market cap of $791.95M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 12.14%
Gross Profit Margin TTM: 47.08%
Debt To Equity: 0.54x
P/S TTM: 4.25x
P/B TTM: 1.61x
Market Cap: $791.95M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Cryoport, Inc. in?

Cryoport, Inc. (CYRX) operates in the Pharmaceutical Preparations industry.

What is CYRX's market cap?

Cryoport, Inc. (CYRX) has a market capitalization of $791.95M as of 2026-06-30.

What exchange does CYRX trade on?

Cryoport, Inc. (CYRX) trades on the Nasdaq.

Where is Cryoport, Inc. incorporated?

Cryoport, Inc. is incorporated in NV.

Cryoport, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Cryoport, Inc. (CYRX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Cryoport, Inc. (CYRX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.